Clinical Trial Update: Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) [Phase 3]

View source ↗

Summary

Phase 3 study update assessing safety and effectiveness of ciclesonide nasal spray for perennial allergic rhinitis over one year; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Perennial Allergic Rhinitis, Allergic Rhinitis | Phase 3 | Status: COMPLETED